Evidence map›Paper›PMID 42507760›Full record

ArticlePLOS global public health2026

Early-evening indoor and outdoor foraging by major malaria vectors in Nchelenge, Zambia.

Mary E Gebhardt, Hannah L Markle, Rachel S Krizek, David Mbewe, Francis Kapasa Mulenga, James Sichivula Lupiya, Erin E Barnett, Mbanga Muleba, Matthew M Ippolito, Jennifer C Stevenson and 2 more

Abstract read
In one paragraph

Article in PLOS global public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Mary E GebhardtThe W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Hannah L MarkleThe W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.ORCID https://orcid.org/0009-0001-9352-537X
Rachel S KrizekThe W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
David MbeweSouthern Africa International Centers of Excellence for Malaria Research, Baltimore, Maryland, United States of America.
Francis Kapasa MulengaSouthern Africa International Centers of Excellence for Malaria Research, Baltimore, Maryland, United States of America.
James Sichivula LupiyaSouthern Africa International Centers of Excellence for Malaria Research, Baltimore, Maryland, United States of America.
Erin E BarnettThe W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.ORCID https://orcid.org/0000-0003-4935-3184
Mbanga MulebaSouthern Africa International Centers of Excellence for Malaria Research, Baltimore, Maryland, United States of America.
Matthew M IppolitoJohns Hopkins Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Jennifer C StevensonDepartment of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America.
William J MossJohns Hopkins Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.ORCID https://orcid.org/0000-0001-6579-3513
Douglas E NorrisThe W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.ORCID https://orcid.org/0000-0002-4631-2777

Funding

TransmissionU19AI089680 · NIAID · JOHNS HOPKINS UNIVERSITY · PI WILLIAM J MOSS · 2010 to 2026
$25.6M
Training: Molecular & Cellular Bases of Infectious DiseasesT32AI007417 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Arturo Casadevall · 1994 to 2026
$11.9M
Malaria and Mosquito/Tick-borne DiseasesT32AI138953 · NIAID · JOHNS HOPKINS UNIVERSITY · PI DAVID Joseph SULLIVAN · 2019 to 2026
$2.0M
NIAID NIH HHS T32 AI007417NIAID NIH HHS T32 AI138953NIAID NIH HHS U19 AI089680
6 · The paper itself

Abstract

Despite a decade of indoor residual spraying, malaria remains holoendemic in Nchelenge District in northern Zambia. This study examined the hypothesis that the intransigence of malaria in Nchelenge District is due in part to early evening and outdoor foraging of local anopheline species. Three replicate collections were performed at 24 households using CDC light traps over 6 weeks during the dry season of 2019. Traps were set indoors, in animal pens, and in outdoor gathering spaces from 16:00-22:00, and overnight indoors in all households during the third replicate. Twelve anopheline species were collected in early-evening traps. The major vector, Anopheles funestus, dominated collections (n = 1,865, 68.2%) and were captured primarily indoors (n = 1,370, 73.4%). Specimens with detectable human blood and Plasmodium falciparum positive specimens were found in all three trap types, indicating that infected anopheline foraging occurred before 22:00. EIR estimates for early-evening anophelines varied spatially and by species and were highest among indoor caught An. funestus at inland locations (18.74 bites/person/6months). There was little difference in anopheline abundance, blooded rates, and sporozoite infection rate when evening and overnight traps were compared, indicating there may be similar anopheline activity before and after 22:00. Overall, this study adds to the growing body of evidence that malaria transmission is not limited to late-night, indoor settings in Nchelenge District, Zambia.

Identifiers

PMID42507760
PMCPMC13405103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.